Literature DB >> 16028006

Optimization and applications of CDAP labeling for the assignment of cysteines.

Gary D Pipes1, Andrew A Kosky, Jeffrey Abel, Yu Zhang, Michael J Treuheit, Gerd R Kleemann.   

Abstract

PURPOSE: The aim of the study is to provide a methodology for assigning unpaired cysteine residues in proteins formulated in a variety of different conditions to identify structural heterogeneity as a potential cause for protein degradation.
METHODS: 1-Cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) was employed for cyanylating free cysteines in proteins and peptides. Subsequent basic cleavage of the peptide bond at the N-terminal side of the cyanylated cysteines provided direct information about their location.
RESULTS: CDAP was successfully employed to a wide variety of labeling conditions. CDAP was reactive between pH 2.0 and 8.0 with a maximum labeling efficiency at pH 5.0. Its reactivity was not affected by excipients, salt or denaturant. Storing CDAP in an organic solvent increased its intrinsic stability. It was demonstrated that CDAP can be employed as a thiol-directed probe to investigate structural heterogeneity of proteins by examining the accessibility of unpaired cysteine residues.
CONCLUSION: CDAP is a unique cysteine-labeling reagent because it is reactive under acidic conditions. This provides an advantage over other sulfhydryl labeling reagents as it avoids potential thiol-disulfide exchange. Optimization of the cyanylation reaction allowed the utilization of CDAP as a thiol-directed probe to investigate accessibility of sulfhydryl groups in proteins under various formulation conditions to monitor structural heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16028006     DOI: 10.1007/s11095-005-5643-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

1.  The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors.

Authors:  C P Hill; T D Osslund; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 2.  Intermediates in the folding reactions of small proteins.

Authors:  P S Kim; R L Baldwin
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

3.  Trapping of intermediates during the refolding of recombinant human epidermal growth factor (hEGF) by cyanylation, and subsequent structural elucidation by mass spectrometry.

Authors:  J Wu; Y Yang; J T Watson
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

4.  A protein caught in a kinetic trap: structures and stabilities of insulin disulfide isomers.

Authors:  Qing-Xin Hua; Wenhua Jia; Bruce H Frank; Nelson F B Phillips; Michael A Weiss
Journal:  Biochemistry       Date:  2002-12-17       Impact factor: 3.162

5.  Reengineering granulocyte colony-stimulating factor for enhanced stability.

Authors:  B Bishop; D C Koay; A C Sartorelli; L Regan
Journal:  J Biol Chem       Date:  2001-06-13       Impact factor: 5.157

6.  Cyanylation of sulfhydryl groups by 2-nitro-5-thiocyanobenzoic acid. High-yield modification and cleavage of peptides at cysteine residues.

Authors:  Y Degani; A Patchornik
Journal:  Biochemistry       Date:  1974-01-01       Impact factor: 3.162

7.  Chemical modification of the Ca(2+)-ATPase of rabbit skeletal muscle sarcoplasmic reticulum: identification of sites labeled with aryl isothiocyanates and thiol-directed conformational probes.

Authors:  A Wawrzynów; J H Collins
Journal:  Biochim Biophys Acta       Date:  1993-11-10

8.  Probing protein folding and stability using disulfide bonds.

Authors:  N Darby; T E Creighton
Journal:  Mol Biotechnol       Date:  1997-02       Impact factor: 2.695

9.  Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartate.

Authors:  Z Shahrokh; G Eberlein; D Buckley; M V Paranandi; D W Aswad; P Stratton; R Mischak; Y J Wang
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

10.  Amino acid sequence of a protease inhibitor isolated from Sarcophaga bullata determined by mass spectrometry.

Authors:  I A Papayannopoulos; K Biemann
Journal:  Protein Sci       Date:  1992-02       Impact factor: 6.725

View more
  9 in total

1.  Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.

Authors:  Mengxin Geng; Frank Austin; Ronald Shin; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2018-02-14       Impact factor: 4.792

2.  Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.

Authors:  Jerome Escano; Byron Stauffer; Jacob Brennan; Monica Bullock; Leif Smith
Journal:  J Bacteriol       Date:  2015-01-20       Impact factor: 3.490

3.  Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain.

Authors:  Arnold McAuley; Jaby Jacob; Carl G Kolvenbach; Kimberly Westland; Hyo Jin Lee; Stephen R Brych; Douglas Rehder; Gerd R Kleemann; David N Brems; Masazumi Matsumura
Journal:  Protein Sci       Date:  2008-01       Impact factor: 6.725

Review 4.  Quantification of thiols and disulfides.

Authors:  Jakob R Winther; Colin Thorpe
Journal:  Biochim Biophys Acta       Date:  2013-04-06

5.  The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.

Authors:  Jerome Escano; Byron Stauffer; Jacob Brennan; Monica Bullock; Leif Smith
Journal:  Microbiologyopen       Date:  2014-11-17       Impact factor: 3.139

6.  High-Throughput Screening for Substrate Specificity-Adapted Mutants of the Nisin Dehydratase NisB.

Authors:  Xinghong Zhao; Rubén Cebrián; Yuxin Fu; Rick Rink; Tjibbe Bosma; Gert N Moll; Oscar P Kuipers
Journal:  ACS Synth Biol       Date:  2020-05-22       Impact factor: 5.110

7.  An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.

Authors:  Xinghong Zhao; Zhongqiong Yin; Eefjan Breukink; Gert N Moll; Oscar P Kuipers
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

8.  Nisin- and Ripcin-Derived Hybrid Lanthipeptides Display Selective Antimicrobial Activity against Staphylococcus aureus.

Authors:  Xinghong Zhao; Oscar P Kuipers
Journal:  ACS Synth Biol       Date:  2021-06-22       Impact factor: 5.110

9.  Semisynthetic Macrocyclic Lipo-lanthipeptides Display Antimicrobial Activity Against Bacterial Pathogens.

Authors:  Xinghong Zhao; Yanli Xu; Jakob H Viel; Oscar P Kuipers
Journal:  ACS Synth Biol       Date:  2021-08-04       Impact factor: 5.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.